Alx Oncology Holdings Inc (ALXO) Insider Ownership

Historic Insider Ownership Trends

ALXO's three largest insider shareholders as of May 14, 2026 are Corey S Goodman (Director, 8.45Mn shares), Associates, Llc Lsv (TenPercentOwner, 2.38Mn shares), Associates, Llc Lsv (TenPercentOwner, 2.38Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Corey S Goodman - 0 8,453,038 04 Feb, 2026
Associates, Llc Lsv - 0 2,383,282 15 Dec, 2021
Associates, Llc Lsv - 0 2,383,282 15 Dec, 2021
Jaume Pons President Cso 579,388 0 21 Feb, 2025
Jaume Pons President Cso 579,388 0 21 Feb, 2025
Sophia Randolph Chief Medical Officer 325,711 0 16 Aug, 2024
Sophia Randolph Chief Medical Officer 325,711 0 16 Aug, 2024
Jason Lettmann Chief Executive Officer 293,609 0 23 Mar, 2026
Jason Lettmann Chief Executive Officer 293,609 0 23 Mar, 2026
Jason Lettmann - 0 285,956 15 Dec, 2021
Jason Lettmann - 0 285,956 15 Dec, 2021
Peter S Garcia Chief Financial Officer 121,516 0 16 Aug, 2024
Shelly Pinto Svp, Finance And Cao 86,805 0 23 Mar, 2026
Shelly Pinto Svp, Finance And Cao 86,805 0 23 Mar, 2026
Harish Shantharam Chief Financial Officer 75,000 0 20 Aug, 2025
Harish Shantharam Chief Financial Officer 75,000 0 20 Aug, 2025
Rekha Hemrajani - 33,000 0 04 Dec, 2024

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
16 Apr, 2026 Jeff E. Knight Stock option (right to buy) A 800,000 $0.00 800,000 D A
16 Apr, 2026 Barbara Klencke Stock option (right to buy) A 100,000 $0.00 100,000 D A
19 Mar, 2026 Shelly Pinto Common Stock D 903 $2.17 86,805 D S
19 Mar, 2026 Shelly Pinto Common Stock D 903 $2.17 86,805 D S
19 Mar, 2026 Jason Lettmann Common Stock D 12,311 $2.17 293,609 D S
19 Mar, 2026 Jason Lettmann Common Stock D 12,311 $2.17 293,609 D S
03 Mar, 2026 Barbara Klencke Stock option (right to buy) A 700,000 $0.00 700,000 D A
18 Feb, 2026 Shelly Pinto Common Stock D 565 $2.27 87,708 D S
18 Feb, 2026 Shelly Pinto Common Stock D 565 $2.27 87,708 D S
17 Feb, 2026 Jason Lettmann Common Stock D 2,201 $2.27 305,920 D F
17 Feb, 2026 Jason Lettmann Common Stock D 2,201 $2.27 305,920 D F
02 Feb, 2026 Corey S Goodman Common Stock A 3,184,713 $1.57 8,453,038 I P
26 Jan, 2026 Harish Shantharam Stock option (right to buy) A 303,000 $0.00 303,000 D A
26 Jan, 2026 Jason Lettmann Stock option (right to buy) A 912,000 $0.00 912,000 D A
26 Jan, 2026 Jason Lettmann Stock option (right to buy) A 912,000 $0.00 912,000 D A
26 Jan, 2026 Shelly Pinto Stock option (right to buy) A 192,000 $0.00 192,000 D A
26 Jan, 2026 Harish Shantharam Stock option (right to buy) A 303,000 $0.00 303,000 D A
26 Jan, 2026 Shelly Pinto Stock option (right to buy) A 192,000 $0.00 192,000 D A
20 Jan, 2026 J. Scott Garland Stock option (right to buy) A 40,400 $0.00 40,400 D A
20 Jan, 2026 Chris H Takimoto Stock option (right to buy) A 40,400 $0.00 40,400 D A